The digestive enzyme market has gained significant traction over the past few years owing to various advantages offered by the products. Digestive enzymes help break down proteins, carbohydrates, and fats into smaller molecules during digestion. They aid in better absorption of nutrients and facilitate smoother digestion. Key products in the market include carbohydrases, proteases, and lipases. Rising working population prone to lifestyle diseases, growing health consciousness, and increasing promotions by manufacturers have driven the demand for digestive enzyme supplements.
The Digestive Enzyme Market size is expected to reach US$ 1,354.2 Mn by 2030, from US$ 715.1 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 9.5% during the forecast period.
Key Takeaways
Key players operating in the digestive enzyme market are National Enzyme Company, Garden of Life LLC , Country Life LLC, Rainbow Light Nutritional System Inc., Food State Inc., Matsun Nutrition , Metagenics, Inc., TwinLab Corporation, Abbott Nutrition, Amway Corporation, Klaire Labs, Zenwise Health LLC, Integrative Therapeutics, LLC , Douglas Labs , Enzymedica Inc., Thorne Research Inc., Pure Encapsulations, LLC, Ortho Molecular Products Inc., Allergy Research Group, and Biotics Research Corp.
The rising prevalence of gastrointestinal disorders like indigestion, bloating, gas, and IBS have fueled the demand for digestive enzymes significantly. Growing healthcare expenditure and evolving consumer lifestyles support their adoption.
Technological advancements have allowed manufacturers to enhance enzyme stability, develop disease-specific formulations, and offer vegetarian and non-GMO options. This increased versatility is expected to drive Digestive Enzyme Market Growth.
Market Trends
Growing demand for vegetarian and vegan supplement options: Rising vegan population has driven the demand for plant-sourced digestive enzyme supplements. Key players have developed vegetarian pepsin and probiotic blends to cater to this trend.
Increasing focus on organic and clean label products: Consumers are shifting to organic and clean label products to avoid chemicals and synthetic ingredients. Players are offering organic and non-GMO verified formulations.
Market Opportunities
Disease-specific formulations: Growing incidence of gastrointestinal disorders presents an opportunity to develop disease-targeted formulations involving specific enzymes.
E-commerce sales: Wide internet proliferation allows players to promote and sell products online, helping penetrate untapped regional markets. Amazon and company websites offer opportunities.
The global digestive enzyme market demonstrates lucrative prospects driven by growing gastrointestinal issues, supplement promotions and innovations. The trends for organic options and disease-focused products also present opportunities.
Impact of COVID-19 on the digestive enzyme market:
The COVID-19 pandemic has significantly impacted the digestive enzyme market. During the initial lockdown phases in 2020, supply chains were disrupted which led to shortages of key raw materials utilized by manufacturers. There was also a decline in demand from the dietary supplement and food & beverage sectors as people focused more on essential items. However, as the pandemic stretched on, demand increased for products supporting immunity and digestive health. Many individuals suffered from issues like acid reflux, bloating and irregular bowel movements due to increased stress, medications and changes in diet and lifestyle during the crisis. This boosted sales of digestive enzymes which help alleviate such common digestive issues. The market is also gaining from rising focus on gut health and its links to overall well-being. Experts anticipate the demand for probiotic and prebiotic ingredients to remain strong even post pandemic. While supply chain bottlenecks continue to be a challenge, manufacturers are working on stabilizing production levels. Going forward, widespread immunity from vaccines is expected to normalize demand trends. However, increased awareness about preventive healthcare is likely to sustain growth of the digestive enzyme market in the long run.
The fastest growing region for the digestive enzyme market:
The Asia Pacific region is poised to be the fastest growing market for digestive enzymes over the forecast period. Rapid economic development, growing health awareness and expanding middle-class have boosted per capita healthcare expenditure in APAC countries. There is a significant prevalence of digestive disorders like constipation, indigestion and IBS in highly populated nations such as India and China. Self-medication with supplements is a common practice in the region. Rising disposable incomes also allow for increased affordability of enzyme products. Manufacturers are introducing innovative formulations tailored to Asian diets and tastes. Additionally, APAC is an attractive destination for outsourcing of production by leading global companies due to low costs. Governments are also supporting the healthcare sector through initiatives fostering research. All of these factors are contributing to increasing adoption of enzyme therapies for digestive illnesses in Asia Pacific. The growing elderly population which is more prone to pancreatic insufficiencies further drives growth.
Get More Insights On - Digestive Enzyme Market
Get this Report in Japanese Language:
Get this Report in Korean Language:
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Write a comment ...